Cogstate is an innovative global neuroscience endpoint company that specializes in the science and service of CNS measurement to ensure clinical trial data is as accurate as it is actionable. Cogstate’s high-tech, high-touch solutions—including fit-for-purpose data quality programs, advanced analytics, and digital cognitive assessment—combine clinical understanding with operational expertise to identify meaningful signals and drive informed study decision making.
For more than 25 years, Cogstate has formed lasting, mission-aligned partnerships with drug developers to power complex neuroscience studies and accelerate the next generation of CNS therapies.